An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study

PHASE4CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

July 13, 2012

Primary Completion Date

September 27, 2019

Study Completion Date

September 27, 2019

Conditions
Neoplasms
Interventions
DRUG

Bevacizumab

Bevacizumab will be administered at 7.5 or 15 milligrams per kilogram (mg/kg) intravenously every 3 weeks (Q3W), or 5 or 10 mg/kg intravenously every 2 weeks (Q2W).

Trial Locations (73)

1122

Orszagos Onkologiai Intezet; Nogyogyaszati Osztaly, Budapest

1632

MBAL Serdika EOOD, Sofia

2193

Wits Donald Gordon Clinical Trial Centre; Medical Oncology, Parktown, Johannesburg

4400

A.Ö. LKH; Abt. für Lungenkrankheiten, Steyr

10126

Azienda Ospedaliera Le Molintte di Torino; Dipartimento Di Neurologia - Oncologia, Turin

13419

North Estonia Medical Centre Foundation; Oncology Center, Tallinn

14004

Hospital Reina Sofia; Medical Oncology, Córdoba

14080

Instituto Nacional de Cancerologia; Oncology, Distrito Federal

15006

Complejo Hospitalario Universitario A Coruña (CHUAC, Materno Infantil), Oncología, A Coruña

20133

Fondazione IRCCS Istituto Neurologico C. Besta; Neuro-oncologia Sperimentale e Terapia Genica, Milan

20141

Irccs Istituto Europeo Di Oncologia (IEO); Oncologia Medica, Milan

20900

ASST DI MONZA; Oncologia Medica, Monza

21000

Centre Georges François Leclerc; Service Pharmacie, Bp 77980, Dijon

22020

ASST LARIANA; Oncologia, S. Fermo Della Battaglia (CO)

22927

LungenClinic Großhansdorf GmbH, Großhansdorf

23007

Complejo Hospitalario de Jaen-Hospital Universitario Medico Quirurgico; Servicio de Oncologia, Jaén

25030

HOPITAL JEAN MINJOZ; Oncologie, Besançon

28007

Hospital Gregorio Marañon, Madrid

28041

Hospital Universitario 12 de Octubre; Servicio de Oncologia, Madrid

28046

Hospital Universitario La Paz; Servicio de Oncologia, Madrid

29010

Hospital Regional Universitario Carlos Haya; Servicio de Oncologia, Málaga

31059

Hopital Larrey; Pneumologie, Toulouse

37000

Fundación Rodolfo Padilla Padilla, A.C.; Oncology, León

40138

Azienda Ospedaliero-Universitaria S.Orsola-Malpighi; Unità Operativa Oncologia Medica, Bologna

46010

Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia, Valencia

48013

Hospital de Basurto; Servicio de Oncologia, Bilbao

48903

Hospital de Cruces; Servicio de Oncologia, Bilbao

55043

Ospedale Nuovo Della Versilia; Divisione Di Oncologia Medica, Lido di Camaiore

56124

A.O. Universitaria Pisana-Ospedale Cisanello; Dipartimento Cardio Toracico-Pneumologia Ii, Pisa

59100

Ospedale Misericordia E Dolce; Oncologia Medica, Prato

59187

Centre Leonard De Vinci;Chimiotherapie, Dechy

60528

Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie, Frankfurt am Main

63188

Mälarsjukhuset, Eskilstuna, Kvinnokliniken, Eskilstuna

67065

Centre Paul Strauss; Oncologie Medicale, Strasbourg

68000

Oaxaca Site Management Organization, Oaxaca City

69373

Centre Leon Berard; Departement Oncologie Medicale, Lyon

72100

Ospedale Antonio Perrino; Oncologia Medica, Brindisi

80131

A.O. Universitaria Federico II Di Napoli; Oncologia Ed Endocrinologia Clinica, Napoli

95126

Centro Catanese Di Oncologia; Oncologia Medica, Catania

115478

Blokhin Cancer Research Center; Combined Treatment, Moscow

117837

Russian Research Center of Roentgenoradiology; Dept of Chemotherapy, Moscow

125284

P.A. Gertsen Cancer Research Inst. ; Chemotherapy Dept, Moscow

143423

City Clinical Oncology Hospital, Moscow

249034

Medical Radiological Scientific Center; Department of Radiotherapy of Gynaecological Disease, Obninsk, Kaluzhskaya Region

400015

Prof. Dr. I. Chiricuta Institute of Oncology, Cluj-Napoca

450054

Bashkirian Republican Clinical Oncology Dispensary, Ufa

656049

Altai Region Oncology Dispensory; Oncology, Barnaul

664035

Regional Oncology Hospital; Oncology, Irkutsk

700106

Euroclinic Center of Oncology SRL, Iași

74605-070

Hospital Araujo Jorge; Departamento de Ginecologia E Mama, Goiânia

90610-000

Hospital Sao Lucas - PUCRS, Porto Alegre

14784-400

Hospital de Cancer de Barretos, Barretos

01246-000

Instituto do Cancer do Estado de Sao Paulo - ICESP, São Paulo

01317-000

Hospital Perola Byington, São Paulo

01509-010

Hospital A. C. Camargo; Oncologia, São Paulo

CEP 01321-001

Hospital Sao Jose, São Paulo

M5G 2M9

University Health Network; Princess Margaret Hospital; Medical Oncology Dept, Toronto

779 00

Fakultni nemocnice Olomouc; Onkologicka klinika, Olomouc

Unknown

Hopital Roger Salengro; Service de Neurologie, Lille

Norrlands universitetssjukhus; Onkologkliniken, Umeå

00152

Azienda Ospedaliera San Camillo Forlanini; U.O.C. Pneumologia Ad Indirizzo Oncologico 1, Rome

6525 GA

Radboud Ziekenhuis; Urologie, 659, Nijmegen

2504 LN

Leyenburg Hospital; Pulmonology, The Hague

040 01

Vychodoslovensky onkologicky ustav, Košice

410-769

National Cancer Center; Medical Oncology, Gyeonggi-do

110-744

Severance Hospital; Internal Medicine, Seoul

138-736

Asan Medical Center, Uni Ulsan Collegemedicine; Dept.Internal Medicine / Divisionhematology/Oncology, Seoul

09006

Complejo Asistencial Universitario De Burgos; Servicio de Oncologia, Burgos

701 85

Universitetssjukhuset Örebro, Onkologiska kliniken, Örebro

01060

Adana City Hospital, Medical Oncology, Adana

CB2 2QQ

Addenbrooke'S Hospital; Dept of Neurosurgery, Cambridge

M2O 4BX

Christie Hospital Nhs Trust; Medical Oncology, Manchester

LL18 5UJ

North Wales Cancer Treatment Centre, Glan Clwyd Hospital, Rhyl

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01588184 - An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study | Biotech Hunter | Biotech Hunter